A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old

NCT06944717 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Norovirus Infections

Interventions

BIOLOGICAL: VXA-G1.1-NN
BIOLOGICAL: VXA-G2.4-NS
BIOLOGICAL: VXA G1.1 NN-T
BIOLOGICAL: VXA G2.4 NS-T

Sponsor

Vaxart